Option Care Health reported third quarter 2026 results with net revenue of $1,493.5 million, up 4.1%, and GAAP diluted earnings per share of $0.38, up 18.8%. The company withdrew its previously disclosed financial guidance and will not host an earnings call because of its pending acquisition by Clayton, Dubilier & Rice, LLC and McKesson Corporation.
Net revenue of $1,493.5 million, up 4.1% year over year; GAAP net income of $57.4 million, up 10.8%
GAAP diluted EPS of $0.38, up 18.8%; adjusted diluted EPS of $0.49, up 8.9%
Financial guidance withdrawn and no earnings conference call, given the pending merger agreement with Clayton, Dubilier & Rice, LLC and McKesson Corporation
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Option Care Health's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$5.65B
+13.0%
$1.27
+3.3%
3.7%
FY2024
$5.00B
+16.2%
$1.23
-16.9%
4.2%
FY2023
$4.30B
+11.2%
$1.48
+78.3%
6.2%
FY2022
$3.87B
+12.5%
$0.83
+7.8%
3.9%
FY2021
$3.44B
+13.4%
$0.77
—
4.1%
Frequently asked questions
When is Option Care Health's next earnings date?
Option Care Health has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did Option Care Health earn last quarter?
For the quarter ended Sep 2026, Option Care Health reported diluted EPS of $0.38 (+18.8% year over year) on revenue of $1.49B (+4.1%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.